Exhaled Breath Condensate (EBC) for SARS-CoV-2 diagnosis still an open debate.

P. Pierucci (Bari, Italy), M. Chironna (Bari, Italy), D. Loconsole (Bari, Italy), M. Tummolo (Bari, Italy), L. Palma (Bari, Italy), M. Cicchetti (Bari, Italy), G. Sanasi (Bari, Italy), S. Piccinno (Bari, Italy), G. Carpagnano (Bari, Italy)

Source: International Congress 2022 – COVID imaging and diagnosis
Session: COVID imaging and diagnosis
Session type: Thematic Poster
Number: 1066

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Pierucci (Bari, Italy), M. Chironna (Bari, Italy), D. Loconsole (Bari, Italy), M. Tummolo (Bari, Italy), L. Palma (Bari, Italy), M. Cicchetti (Bari, Italy), G. Sanasi (Bari, Italy), S. Piccinno (Bari, Italy), G. Carpagnano (Bari, Italy). Exhaled Breath Condensate (EBC) for SARS-CoV-2 diagnosis still an open debate.. 1066

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.